# Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Rectal Cancer Patients

> **NCT00574353** · NA · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 23 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **RADIATION:** Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission

## Key facts

- **NCT ID:** NCT00574353
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-12-11
- **Primary completion:** 2024-07-05
- **Final completion:** 2024-07-05
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00574353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00574353, "Study Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography to Detect Hypoxia in Locally Advanced (T3-T4 and./or N1)Primary Rectal Cancer Patients". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00574353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*